Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
MyeloXen
print preview
bookmark
share with colleague
General Information
Company
Pharmsynthez JSC
Description
Liposomal vaccine comprised of peptides homologous to immunogenic sites of the myelin basic protein
Molecular Target
Mechanism of Action
Vaccine
Latest Stage of Development
Phase I/II
Indication
Multiple sclerosis (MS)
Partner
Xenetic Biosciences plc
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information